Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Disease area: Interstitial lung diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
K. Song (Seoul, Republic of Korea), J. Ahn (Seoul, Republic of Korea), Y. Koh (Seoul, Republic of Korea). Effectiveness of corticosteroid in diffuse alveolar hemorrhage with hematologic malignancy. 1401

Member's Comments

No comment yet.

Related content which might interest you: Improvement in SARS-CoV2 lung interstitial injuries with systemic corticosteroid treatment Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021 Pulmonary vasculitis presenting as acute diffuse alveolar haemorrhage (DAH) Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon Year: 2018 Clinical features and outcomes of patients with diffuse alveolar hemorrhage during antithrombotic therapy Source: International Congress 2014 – ILDs 5 Year: 2014 Diffuse alveolar hemorrhage and pulmonary fibrosis in MPO-ANCA-associated vasculitides Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005 Diffuse alveolar haemorrhage Source: Eur Respir Monogr 2019; 86: 173-187 Year: 2019 Lymphoid hyperplasia and eosinophilic pneumonia as histologic manifestations of amiodarone-induced lung toxicity Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Diffuse alveolar haemorrhage and pneumomediastinum after hypoglycaemic seizure Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Idiopathic pulmonary haemosiderosis revisited Source: Eur Respir J 2004; 24: 162-169 Year: 2004 Simultaneous existence of diffuse alveolar damage and subpleural limited usual interstitial pneumonia lesion ( focal-UIP ) in clinical acute interstitial pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 43s Year: 2003 Diffuse alveolar hemorrhage - review of an interstitial lung disease clinic Source: International Congress 2017 – Rare diseases Year: 2017 Extracorporeal membrane oxygenation as rescue therapy for severe ARDS due to autoimmune diffuse alveolar haemorrhage Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019 Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia Source: Eur Respir J 2005; 25: 528-533 Year: 2005 The causes of hemoptysis and lung hemorrhage in patients with pulmonary sarcoidosis Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease Source: Eur Respir Rev 2009; 18: 129-132 Year: 2009 Diffuse idiopathic pulmonary neuroendocrine hyperplasia, chronic eosinophilic pneumonia, and asthma Source: Eur Respir J 2009; 34: 1489-1492 Year: 2009 Heparin-induced thrombocytopenia in patients with massive lung embolism, left-sided pneumonia and uterine tumor Source: Eur Respir J 2007; 30: Suppl. 51, 81s Year: 2007 Lymphoid interstitial pneumonia: clinical features, associations and prognosis Source: Eur Respir J 2006; 28: 364-369 Year: 2006 Recurrent eosinophilic pneumonia in an asthmatic patient treated with sequential montelukast/zafirlukast after corticosteroid withdrawal Source: Eur Respir J 2002; 20: Suppl. 38, 52s Year: 2002 Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Diffuse idiopathic pulmonary endocrine cell hyperplasia (DIPNECH) requiring bilateral sequential lung transplant Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013